BSTC Financial Facts
Diluted net income (loss) per share: 0.42Total Cost and Expenses: 2.16M
See Full Income Statement
Deferred tax assets -long term: 3.37M
Total stockholders' equity: 53.22M
See Full Balance Sheet
BioSpecifics Technologies Corp. (BSTC) Earnings
|
Expand Research on BSTC
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -0.2% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +0.3% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
3/11/11 | Q410 | $0.02 | -$0.04 | +$0.06 | $1.1M | $1.38M | N/A | Details | |||
3/9/12 | Q411 | $0.01 | N/A | N/A | $2.6M | $1.1M | N/A | Details | |||
8/9/12 | Q212 | $0.11 | $0.07 | +$0.04 | $2.6M | $2.5M | N/A | Details | |||
5/8/14 | Q114 | $0.12 | $0.07 | +$0.05 | $2.8M | $2.46M | N/A | Details | |||
11/8/11 | Q311 | $0.04 | N/A | N/A | $1.9M | $1M | N/A | Details | |||
8/10/15 | Q215 | $0.24 | N/A | N/A | $4.7M | $2.6M | N/A | Details | |||
5/11/15 | Q414 | $0.32 | N/A | N/A | $5.6M | $2.3M | N/A | Details | |||
8/11/14 | Q214 | $0.09 | $0.12 | -$0.03 | $2.7M | $2.91M | N/A | Details |